CANMAB 150MG

What is CANMAB 150MG?

CANMAB 150MG is an anti-cancer (antineoplastic) medication that contains the active ingredient Trastuzumab. It is a monoclonal antibody specifically designed to target the HER2 (human epidermal growth factor receptor 2) protein, which promotes the growth of cancer cells. CANMAB is the biosimilar version of Herceptin® and is manufactured by Biocon Biologics.

---

What is the use of CANMAB 150MG?

CANMAB 150MG is used in the treatment of HER2-positive cancers, including:

• HER2-positive breast cancer (early and metastatic)

• HER2-positive metastatic gastric cancer

It may be used alone or in combination with chemotherapy such as paclitaxel, docetaxel, or other regimens, depending on the cancer stage and treatment plan.

---

Benefits of CANMAB 150MG:

• Targeted therapy that specifically attacks HER2-positive cancer cells

• Proven efficacy in reducing tumor size and slowing disease progression

• Improves survival rates and quality of life in HER2-positive breast and gastric cancer patients

• Can be used in neoadjuvant (before surgery), adjuvant (after surgery), or metastatic settings

• A cost-effective biosimilar alternative to innovator trastuzumab brands

---

Side Effects of CANMAB 150MG:

Like all anticancer drugs, CANMAB can cause side effects. Patients should be monitored closely during therapy.

Common Side Effects:

• Fever, chills during infusion

• Fatigue, weakness

• Nausea, vomiting

• Diarrhea

• Headache

• Rash or skin irritation

Serious Side Effects (require immediate medical attention):

• Heart problems (especially in patients with previous heart disease or those receiving anthracyclines)

• Infusion-related reactions (difficulty breathing, swelling, low blood pressure)

• Liver enzyme elevation

• Low blood cell counts

⚠️ Note: Cardiac function must be monitored during treatment. Dose adjustments or discontinuation may be required in case of cardiotoxicity.

---

Important Usage Information:

• Administered intravenously under the supervision of a qualified oncologist

• Pre-medications may be given to reduce the risk of infusion reactions

• Not recommended during pregnancy or breastfeeding

• Requires cardiac function tests (e.g., echocardiogram) before and during treatment

• What is CANMAB 150MG used for?
  CANMAB 150MG is used to treat HER2-positive breast cancer and metastatic gastric cancer. It is typically used in combination with other chemotherapy drugs.

• What is the active ingredient in CANMAB 150MG?
  The active ingredient is Trastuzumab, a monoclonal antibody that targets the HER2 receptor on cancer cells.

• How does CANMAB 150MG work?
  It binds to the HER2 receptors on cancer cells and inhibits their growth and survival. It also activates the immune system to destroy these cells.

• Is CANMAB 150MG a chemotherapy drug?
  No, it is not traditional chemotherapy. It is a targeted therapy, specifically a monoclonal antibody, used alongside chemotherapy.

• How is CANMAB 150MG administered?
  CANMAB 150MG is administered as an intravenous (IV) infusion under the supervision of a healthcare professional.

• How often is CANMAB 150MG given?
  It is usually given every week or every 3 weeks, depending on the treatment regimen and patient response.

• Can CANMAB 150MG cause side effects?
  Yes. Common side effects include fever, chills, nausea, fatigue, headache, and rash. Serious side effects can include heart problems and allergic reactions.

• Is cardiac monitoring required with CANMAB 150MG?
  Yes. Echocardiograms or MUGA scans are recommended regularly to monitor heart function during treatment.

• Is CANMAB 150MG safe during pregnancy?
  No. It is not recommended during pregnancy due to the risk of harm to the unborn baby. Effective contraception is advised during and for 7 months after treatment.

• Can CANMAB 150MG be used alone?
  In some cases, yes. However, it is often more effective when used in combination with chemotherapy or other targeted therapies.

• What should I do if I miss a dose of CANMAB 150MG?
  Contact your doctor immediately. Your healthcare provider will decide when to reschedule the missed dose.

• Are there any special precautions while using CANMAB 150MG?
  Yes. Inform your doctor if you have a history of heart disease, are pregnant or breastfeeding, or are taking any other medications.

• How long does treatment with CANMAB 150MG last?
  Treatment duration varies but may continue for up to a year or longer, based on response and tolerance.

• Can I take other medications with CANMAB 150MG?
  Inform your doctor about all the medications and supplements you’re taking to avoid potential drug interactions.

• Is CANMAB 150MG effective for all types of breast cancer?
  No. It is effective only in patients with HER2-positive tumors. HER2 status must be confirmed before starting treatment.